整形外科的Meta分析:结果可信吗?
多数Meta分析纳入中低级别证据原始研究,仅16.2%包含随机对照试验,阳性结果占81.1%,中位AMSTAR评分为7/11。尽管数量与质量有所提升,但因原始研究证据级别低及异质性,Meta分析存在高偏倚风险。
要点
- 整形外科Meta分析数量逐年增加,但仅16.2%纳入随机对照试验,证据级别偏低。
- 81.1%报告阳性结果,77.0%报告显著结果,提示可能存在发表偏倚。
- 中位AMSTAR评分为7/11,质量与是否提供合并理由及处理异质性相关。
核心结论
- 整形外科Meta分析数量和质量有所提升,但因纳入原始研究证据级别低及异质性,仍存在高偏倚风险。
主要发现
- 每年Meta分析数量增加,大多数评估单一干预(59.5%),平均合并20.9项研究(范围2至134),平均2463例患者(范围44至14884)。
- 大多数Meta分析发表于Plastic and Reconstructive Surgery(44.6%),纳入中级别证据(II至IV)原始研究,仅16.2%包含随机对照试验。
- Meta分析通常报告阳性结果(81.1%)和显著结果(77.0%)。
- 中位AMSTAR评分为7/11(四分位距5至8),更高的AMSTAR评分与更近期的Meta分析、提供统计合并理由及适当处理方法学异质性相关(r=0.66;p<0.01)。
临床怎么用
- 整形外科医生应意识到开展和解读Meta分析时的陷阱,谨慎看待其结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meta-analyses are common in the plastic surgery literature, but studies concerning their quality are lacking. The authors assessed the overall quality of meta-analyses in plastic surgery, and attempted to identify variables associated with scientific quality. METHODS: A systematic review of meta-analyses published in seven plastic surgery journals between 2007 and 2017 was undertaken. Publication descriptors and methodologic details were extracted. Articles were assessed using the following two instruments: A Measurement Tool to Assess Systematic Reviews (AMSTAR) and AMSTAR 2. RESULTS: Seventy-four studies were included. The number of meta-analyses per year increased. Most meta-analyses assessed a single intervention (59.5 percent), and pooled a mean of 20.9 studies (range, two to 134), including a mean of 2463 patients (range, 44 to 14,884). Most meta-analyses were published in Plastic and Reconstructive Surgery (44.6 percent) and included midlevel evidence (II to IV) primary studies. Only 16.2 percent of meta-analyses included randomized controlled trials. Meta-analyses generally reported positive (81.1 percent) and significant results (77.0 percent). Median AMSTAR score was 7 of 11 (interquartile range, 5 to 8). Higher AMSTAR scores correlated with more recent meta-analyses that provided a rationale for statistical pooling, and appropriately managed methodologic heterogeneity (r = 0.66; p < 0.01). CONCLUSIONS: Despite an increase in number and quality, meta-analyses are at high risk of bias because of the low level of evidence of included primary studies and heterogeneity within and between primary studies. Plastic surgeons should be aware of the pitfalls of conducting and interpreting meta-analyses.
引用
- McGuire C, Samargandi OA, Corkum J, et al. Meta-Analyses in Plastic Surgery: Can We Trust Their Results? Plast Reconstr Surg. 2019. PMID: 31348375. doi:10.1097/PRS.0000000000005880
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。